NVAX — Novavax Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Novavax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	711	1,515	1,337	569	923
Net Total Accounts Receivable
Net Total Receivables	262	455	82.4	297	108
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,248	2,155	1,703	1,144	1,129
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	188	269	400	491	300
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	1,582	2,577	2,259	1,797	1,560
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	580	2,390	2,460	1,635	1,154
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	955	2,928	2,893	2,514	2,184
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	627	-352	-634	-717	-624
Total Liabilities & Shareholders' Equity	1,582	2,577	2,259	1,797	1,560
Total Common Shares Outstanding